| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Barbui, Tiziano |
| dc.contributor.author | Iurlo, Alessandra |
| dc.contributor.author | Masciulli, Arianna |
| dc.contributor.author | Carobbio, Alessandra |
| dc.contributor.author | Ghirardi, Arianna |
| dc.contributor.author | Rossi, Giuseppe |
| dc.contributor.author | Fox, Maria Laura |
| dc.date.accessioned | 2022-04-06T07:03:34Z |
| dc.date.available | 2022-04-06T07:03:34Z |
| dc.date.issued | 2021-06-16 |
| dc.identifier.citation | Barbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Rossi G, et al. Long-term follow-up of recovered MPN patients with COVID-19. Blood Cancer J. 2021 Jun 16;11:115. |
| dc.identifier.issn | 2044-5385 |
| dc.identifier.uri | https://hdl.handle.net/11351/7308 |
| dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Chronic myeloproliferative neoplasms |
| dc.description.abstract | During the first wave of SARS-CoV-2 infection a European observational study was launched under the auspices of the European Leukemia Net (ELN), aiming at gathering information about the clinical epidemiology of COVID-19 in patients with chronic myeloproliferative neoplasms (MPN-COVID study). |
| dc.language.iso | eng |
| dc.publisher | Springer Nature |
| dc.relation.ispartofseries | Blood Cancer Journal;11 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | COVID-19 (Malaltia) - Tractament |
| dc.subject | Trastorns mieloproliferatius - Complicacions |
| dc.subject | Avaluació de resultats (Assistència sanitària) |
| dc.subject.mesh | Myeloproliferative Disorders |
| dc.subject.mesh | /complications |
| dc.subject.mesh | Coronavirus Infections |
| dc.subject.mesh | /therapy |
| dc.title | Long-term follow-up of recovered MPN patients with COVID-19 |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1038/s41408-021-00509-0 |
| dc.subject.decs | trastornos mieloproliferativos |
| dc.subject.decs | /complicaciones |
| dc.subject.decs | infecciones por Coronavirus |
| dc.subject.decs | /terapia |
| dc.relation.publishversion | https://doi.org/10.1038/s41408-021-00509-0 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Barbui T, Masciulli A, Carobbio A, Ghirardi A] FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy. [Iurlo A] Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy. [Rossi G] Spedali Civili, Brescia, Italy. [Fox ML] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| dc.identifier.pmid | 34135309 |
| dc.identifier.wos | 000664631700002 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |
